JNJ Johnson & Johnson

NYSE
$263.81

Johnson & Johnson (JNJ) is expected to report earnings on January 12, 2027, before the market open. The consensus earnings estimate is $2.91 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.6% since its last earnings release on October 13, 2026.

Johnson & Johnson Missed Expectations, Revises Guidance
Tuesday, October 13, 2026 · 6:20 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 12
Tuesday · 6:20 AM ET
Earnings Whisper
-
vs $2.91
Rev est $26.39B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $255.52

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.

Sector

Healthcare

Industry

Drug Manufacturers / Major

Held By 11 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.